Roquinimex

DB11366ExperimentalSmall molecule

Roquinimex is a derivative of quinoline that presents immunostimulant properties. Its effects are suggested to increase the activity of NK cells and macrophage cytotoxicity. Additionally, roquinimex is known to inhibit...

Chemical structure of Roquinimex
Primary indication
Roquinimex is investigated to be used as a treatment of a number of cancers and autoimmune conditions.Curator reviewed
Formula / weight
C18H16N2O3 · 308.337 g/mol (avg)
Also known as
Linomide
Code names
FCF-89 · LS 2616

Resolves to

Compound
UNII372T2944C0CAS84088-42-6ChEMBLCHEMBL11672ChEBI92056PubChem54676478
Clinical / RWD
ATCL03AX02
Structure
InChIKeySGOOQMRIPALTEL-UHFFFAOYSA-NSMILESCN(C(=O)C1=C(O)C2=C(C=CC=C2)N(C)C1=O)C1=CC=CC=C1
Targets
P60568IL2

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
48Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 10 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Roquinimex, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In